Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Interim PET-CT Scan-guided Response Adapted Therapy in Hodgkin's Lymphoma

NCT01304849 is registered in ClinicalTrials.gov with Cancer Institute WIA as lead sponsor.

NCT NCT01304849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01304849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Interim PET-CT Scan-guided Response Adapted Therapy in Hodgkin's Lymphoma
Lead sponsor
Cancer Institute WIA
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
September 30, 2013
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin's lymphoma